Giuseppe Curigliano, MD, PhD, is the director of the Early Drug Development Division and holds the co-chair for Experimental Therapeutics Program at the European Institute of Oncology, a comprehensive cancer center in Milano, Italy. He is professor of Medical Oncology in the Department of Oncology and Hemato-Oncology at the University of Milano. Moreover, he is member of the Italian National Health Council, serving as advisor of the Ministry of Health for cancer policy issues. HProfessor Curigliano was identified as Clarivate™ world’s most influential researchers (the highly cited researchers) in 2022, 2023 and 2024. He has authored more than 800 papers in peer-reviewed journals (h-index 96) and many book chapters. He served as editorial board member for international journals in oncology (European Journal of Oncology, Journal of Clinical Oncology, Annals of Oncology). Prof. Curigliano is currently serving as Editor in Chief of ESMO Open. He is ESMO President elect.